Nacl B. Braun (Sodium Chloride)

Sodium Chloride, the active ingredient in Nacl B. Braun, is an excipient presented as a sterile solution for intramuscular use. It helps restore sodium and chloride balance in patients requiring fluid and electrolyte replenishment.

GNH USA supplies Nacl B. Braun as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Nacl B. Braun is used in clinical situations that require restoration of extracellular fluid volume and electrolyte balance. - Electrolyte replacement: restores sodium and chloride levels in patients with deficits. - Fluid therapy: provides isotonic fluid to maintain intravascular volume during surgery or trauma. - Dehydration treatment: corrects mild to moderate dehydration by supplying essential ions. - Hyponatremia management: raises serum sodium concentration in low‑sodium states.

Adverse reactions may occur with any parenteral electrolyte solution.

Common Side Effects: - Local irritation at the injection site: mild pain or redness. - Hypernatremia: elevated serum sodium if administered excessively. - Hyperchloremia: increased chloride levels leading to metabolic acidosis.

Serious or Rare Side Effects: - Severe allergic reaction: anaphylaxis or urticaria. - Fluid overload: pulmonary edema in patients with compromised cardiac function. - Electrolyte imbalance: rapid shifts causing cardiac arrhythmias. - Infection: contamination of the injection site or solution.

Use Nacl B. Braun with clinical monitoring of fluid and electrolyte status. - Patient assessment: evaluate baseline serum electrolytes before administration. - Volume control: avoid excess dosing in patients with heart or renal failure. - Compatibility: verify compatibility with other intravenous solutions. - Monitoring: observe for signs of hypernatremia or fluid overload during therapy. - Storage: Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Sodium chloride can influence the pharmacokinetics or safety of certain co‑administered agents.

Major Interactions (Avoid): - Loop diuretics: may exacerbate electrolyte loss, increasing risk of hyponatremia. - ACE inhibitors or ARBs: can potentiate hyperkalemia when combined with high sodium loads.

Moderate Interactions (Monitor Closely): - Lithium: altered renal clearance may increase lithium toxicity. - Anticonvulsants (e.g., carbamazepine): sodium shifts can affect drug levels. - Corticosteroids: may enhance sodium retention, requiring electrolyte monitoring.